Novel genetic and epigenetic alterations in ... - Ous-research.no
Share Embed Flag
Download ePaper

Novel genetic and epigenetic alterations in ... - Ous-research.no

Novel genetic and epigenetic alterations in ... - Ous-research.no Novel genetic and epigenetic alterations in ... - Ous-research.no

ous.research.no
from ous.research.no More from this publisher
11.07.2015 Views

References196. Honda S, Haruta M, Sugawara W, Sasaki F, Ohira M, Matsunaga T, Yamaoka H,Horie H, Ohnuma N, Nakagawara A, Hiyama E, Todo S, Kaneko Y (2008) Themethylation status of RASSF1A promoter predicts responsiveness tochemotherapy and eventual cure in hepatoblastoma patients. Int J Cancer123(5): 1117-1125197. Koul S, McKiernan JM, Narayan G, Houldsworth J, Bacik J, Dobrzynski DL, AssaadAM, Mansukhani M, Reuter VE, Bosl GJ, Chaganti RS, Murty VV (2004) Role ofpromoter hypermethylation in Cisplatin treatment response of male germ celltumors. Mol Cancer 3 16198. Punt CJ, Buyse M, Kohne CH, Hohenberger P, Labianca R, Schmoll HJ, Pahlman L,Sobrero A, Douillard JY (2007) Endpoints in adjuvant treatment trials: asystematic review of the literature in colon cancer and proposed definitionsfor future trials. J Natl Cancer Inst 99(13): 998-1003199. Sargent DJ, Wieand HS, Haller DG, Gray R, Benedetti JK, Buyse M, Labianca R,Seitz JF, O'Callaghan CJ, Francini G, Grothey A, O'Connell M, Catalano PJ, BlankeCD, Kerr D, Green E, Wolmark N, Andre T, Goldberg RM, De GA (2005)Disease-free survival versus overall survival as a primary end point foradjuvant colon cancer studies: individual patient data from 20,898 patients on18 randomized trials. J Clin Oncol 23(34): 8664-8670200. Platell CF, Semmens JB (2004) Review of survival curves for colorectal cancer.Dis Colon Rectum 47(12): 2070-2075201. Greenman C, Wooster R, Futreal PA, Stratton MR, Easton DF (2006) Statisticalanalysis of pathogenicity of somatic mutations in cancer. Genetics 173(4):2187-2198202. Sjöblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, LearyRJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD,Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G,Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE(2006) The consensus coding sequences of human breast and colorectalcancers. Science 314(5797): 268-274203. Torkamani A, Schork NJ (2008) Prediction of cancer driver mutations in proteinkinases. Cancer Res 68(6): 1675-1682204. Duval A, Rolland S, Compoint A, Tubacher E, Iacopetta B, Thomas G, Hamelin R(2001) Evolution of instability at coding and non-coding repeat sequences inhuman MSI-H colorectal cancers. Hum Mol Genet 10(5): 513-518205. Duval A, Hamelin R (2002) Mutations at coding repeat sequences in mismatchrepair-deficient human cancers: toward a new concept of target genes forinstability. Cancer Res 62(9): 2447-245484

References206. Esteller M (2007) Cancer epigenomics: DNA methylomes and histonemodificationmaps. Nat Rev Genet 8(4): 286-298207. Schuebel KE, Chen W, Cope L, Glockner SC, Suzuki H, Yi JM, Chan TA, Van NL,Van CW, van den BS, van EM, Ting AH, Jair K, Yu W, Toyota M, Imai K, Ahuja N,Herman JG, Baylin SB (2007) Comparing the DNA hypermethylome with genemutations in human colorectal cancer. PLoS Genet 3(9): 1709-1723208. Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, WrightFA, Feramisco JD, Peltomaki P, Lang JC, Schuller DE, Yu L, Bloomfield CD,Caligiuri MA, Yates A, Nishikawa R, Su HH, Petrelli NJ, Zhang X, O'Dorisio MS,Held WA, Cavenee WK, Plass C (2000) Aberrant CpG-island methylation hasnon-random and tumour-type-specific patterns. Nat Genet 24(2): 132-138209. Liu ET (2008) Functional genomics of cancer. Curr Opin Genet Dev 18(3): 251-256210. Buffart TE, Overmeer RM, Steenbergen RD, Tijssen M, van Grieken NC, SnijdersPJ, Grabsch HI, van d, V, Carvalho B, Meijer GA (2008) MAL promoterhypermethylation as a novel prognostic marker in gastric cancer. Br J Cancer99(11): 1802-180785

References206. Esteller M (2007) Cancer epige<strong>no</strong>mics: DNA methylomes <strong>and</strong> histonemodificationmaps. Nat Rev Genet 8(4): 286-298207. Schuebel KE, Chen W, Cope L, Glockner SC, Suzuki H, Yi JM, Chan TA, Van NL,Van CW, van den BS, van EM, T<strong>in</strong>g AH, Jair K, Yu W, Toyota M, Imai K, Ahuja N,Herman JG, Bayl<strong>in</strong> SB (2007) Compar<strong>in</strong>g the DNA hypermethylome with genemutations <strong>in</strong> human colorectal cancer. PLoS Genet 3(9): 1709-1723208. Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, WrightFA, Feramisco JD, Peltomaki P, Lang JC, Schuller DE, Yu L, Bloomfield CD,Caligiuri MA, Yates A, Nishikawa R, Su HH, Petrelli NJ, Zhang X, O'Dorisio MS,Held WA, Cavenee WK, Plass C (2000) Aberrant CpG-isl<strong>and</strong> methylation has<strong>no</strong>n-r<strong>and</strong>om <strong>and</strong> tumour-type-specific patterns. Nat Genet 24(2): 132-138209. Liu ET (2008) Functional ge<strong>no</strong>mics of cancer. Curr Op<strong>in</strong> Genet Dev 18(3): 251-256210. Buffart TE, Overmeer RM, Steenbergen RD, Tijssen M, van Grieken NC, SnijdersPJ, Grabsch HI, van d, V, Carvalho B, Meijer GA (2008) MAL promoterhypermethylation as a <strong>no</strong>vel prog<strong>no</strong>stic marker <strong>in</strong> gastric cancer. Br J Cancer99(11): 1802-180785

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!